Клиническая онкогематология. Фундаментальные исследования и клиническая практика
Clinical Oncohematology. Basic Research and Clinical Practice
ISSN 1997-6933 (print)
ISSN 2500-2139 (online)
Русский English
  • Register
  • Login
Skip to main content Skip to main navigation menu Skip to site footer
Clinical Oncohematology
Basic Research and Clinical Practice

ИФ РИНЦ:     0,587
H-INDEX:        16

  • Home
  • About the Journal
    • Aims and Scope
    • Editorial Masthead
    • Peer Review
    • Publishing Ethics and Malpractice Statement
    • Indexing and Abstracting
    • Ownership, management and funding
    • Open Access Policy and Publication Fee
  • Articles
    • Current
    • Journal pre-proofs
    • Archive
    • SUPPLEMENT
  • Sections
    • LYMPHOID TUMORS
    • MYELOID TUMORS
    • BONE MARROW TRANSPLANTATION
    • ANEMIAS
    • AUTOIMMUNE DISEASES
    • CLINICAL TRIALS
    • NOVEL CORONAVIRUS INFECTION
    • NEWS
    • NEW TECHNOLOGIES
    • REVIEWS
    • COMPLICATIONS OF CHEMOTHERAPY
    • PRACTICAL RECOMMENDATIONS
    • RARE HEMATOLOGICAL TUMORS AND SYNDROMES
    • EXPERIMENTAL STUDIES
  • Submission
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Evolution of Anti-Cancer Treatment and its Impact on Surrogate Prognostic Factors in Multiple Myeloma

    Aleksandr Sergeevich Luchinin, S.V. Semochkin, N.V. Minaeva, N.M. Pozdeev, I.V. Paramonov
    175-181
    01.04.2018
  • Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs

    Ol’ga Vladislavovna Pirogova, E.I. Darskaya, V.V. Porunova, O.V. Kudyasheva, A.G. Smirnova, I.S. Moiseev, E.V. Babenko, B.V. Afanas’ev
    187-191
    01.04.2018
  • Minimal Residual Disease and IGHV-Genes Mutational Status as the Main Predictors of Response to Bendamustine-Rituximab Therapy in Previously Untreated Chronic Lymphocytic Leukemia

    Yuliya Vladimirovna Mirolyubova, E.A. Stadnik, V.V. Strugov, T.O. Andreeva, T.S. Nikulina, Yu.V. Virts, P.A. Butylin, A.G. Rumyantsev, A.Yu. Zaritskey
    167-174
    01.04.2018
  • First-Line Treatment of Mantle-Cell Lymphoma: Analysis of Effectiveness and Cost-Effectiveness

    Kamil’ Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, A.L. Shipaeva, I.V. Matveeva, M.N. Shirokova, A.C. Proskurina, N.A. Red’kina, E.G. Gemdzhyan
    150-159
    01.04.2018
  • Prognostic Value of Genetic Markers for Efficacy Estimation of Induction Treatment Including Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients

    Elena L’vovna Nazarova, N.V. Minaeva, M.N. Khorobrykh, E.E. Sukhorukova, V.I. Shardakov, I.V. Paramonov, N.A. Zorina
    54-69
    01.01.2018
  • Ibrutinib in the Treatment of Relapsed Chronic Lymphocytic Leukemia

    Elena Aleksandrovna Stadnik, N.S. Timofeeva, V.V. Strugov, A.Yu. Zaritskey
    42-49
    01.01.2018
  • Conventional and Conformal Radiotherapy with and without Beam Intensity Modulation in Patients with Stage II Hodgkin’s Lymphoma with Supradiaphragmal Lesions

    Yu.N. Vinogradova, E.I. Ivanova, A.I. Chumachenko, E.V. Smirnova, G.I. Andreev, A.M. Kalesnik, N.A. Vorob’ev, N.V. Il’in
    70-77
    01.01.2018
  • First-Line Therapy for Patients with Advanced Hodgkin’s Lymphoma: Efficacy and Toxicity of Intensive ЕАСОРР-14 Program (NN Blokhin National Medical Cancer Research Center Data)

    Elena Andreevna Demina, A.A. Leont’eva, G.S. Tumyan, Yu.E. Ryabukhina, O.P. Trofimova, N.V. Volkova, Yu.I. Pryamikova, V.M. Sotnikov, V.B. Larionova, E.G. Medvedovskaya, E.V. Paramonova, L.V. Manzyuk, N.A. Probatova, N.V. Kokosadze, E.A. Osmanov
    443-452
    01.10.2017
  • Plasma cell neoplasms in HIV-Infected Patients: A Literature Review and Case Series

    R.A. Leigton, Aleksandr Vasil’evich Pivnik, E.P. Sergeeva, N.V. Kremneva, O.V. Mukhin
    464-470
    01.10.2017
  • Targeted Therapy of Myelofibrosis

    Ol’ga Yur’evna Vinogradova, V.A. Shuvaev, I.S. Martynkevich, M.M. Pankrashkina, M.S. Fominykh, E.V. Efremova, K.Yu. Krutikova, L.B. Polushkina, N.N. Sharkunov, S.V. Voloshin, A.V. Chechetkin
    471-478
    01.10.2017
  • The Comparison of De Novo Grade 3 Follicular Lymphoma and Transformed Grade 3 Follicular Lymphoma: Own Data

    Lyubov’ Vasil’evna Plastinina, A.M. Kovrigina, T.N. Obukhova, E.S. Nesterova, A.U. Magomedova, Ya.K. Mangasarova, A.E. Misyurina, F.E. Babaeva, S.M. Kulikov, A.I. Vorob’ev, S.K. Kravchenko
    453-463
    01.10.2017
  • Supportive (Maintenance) Therapy in Hematopoietic Stem Cell Transplantation: Main Principles and New Perspectives

    Vasilii Petrovich Pop, O.A. Rukavitsyn
    501-513
    01.10.2017
  • Ibrutinib in the Treatment of Refractory Chronic Lymphocytic Leukemia

    Evgenii Aleksandrovich Nikitin, E.A. Dmitrieva, M.A. Panteleev, E.I. Emelina, V.L. Ivanova, Yu.B. Kochkareva, E.G. Arshanskaya, I.E. Lazarev, E.E. Markova, L.A. Mukha, N.G. Novitskaya, M.M. Pankrashkina, V.V. Glazunova, A.V. Shubina, S.A. Chernysh, N.K. Khuazheva, E.V. Naumova, S.A. Lugovskaya, M.E. Pochtar’, T.N. Obukhova, O.Yu. Vinogradova, G.E. Gendlin, V.V. Ptushkin
    271-281
    01.07.2017
  • The Role of Hypomethylating Agents Prior to Allogeneic Hematopoietic Stem Cells Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

    Varvara Nikolaevna Ovechkina, S.N. Bondarenko, E.V. Morozova, I.S. Moiseev, A.A. Osipova, T.L. Gindina, A.I. Shakirova, T.A. Bykova, A.D. Kulagin, I.A. Samorodova, E.V. Karyakina, E.A. Ukrainchenko, L.S. Zubarovskaya, B.V. Afanas’ev
    351-357
    01.07.2017
  • Pomalidomide in Combination with Low-Dose Dexamethasone as the Treatment of “Double Refractory” Multiple Myeloma

    Aleksei Vladilenovich Petrov, D.V. Motorin, O.S. Pokrovskaya, E.S. Urnova, M.V. Nareiko, D.V. Babenetskaya, Yu.A. Alekseeva, L.L. Girshova, L.P. Mendeleeva, A.Yu. Zaritskii
    372-380
    01.07.2017
  • Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children

    Natal’ya Andreevna Batmanova, M.A. Shervashidze, A.V. Popa, L.Yu. Grivtsova, I.N. Serebryakova, G.L. Mentkevich
    381-389
    01.07.2017
  • Molecular Genetic Markers and Clinical Characteristics of Essential Thrombocythemia

    Anastasiya Andreevna Zhernyakova, I.S. Martynkevich, V.A. Shuvaev, L.B. Polushkina, M.S. Fominykh, V.Yu. Udal’eva, I.I. Zotova, D.I. Shikhbabaeva, M.N. Zenina, N.A. Potikhonova, S.V. Voloshin, S.S. Bessmel’tsev, A.V. Chechetkin, K.M. Abdulkadyrov
    402-408
    01.07.2017
  • Acute Lymphoblastic Leukemia with t(4;11)(q21;q23)/KMT2A-AFF1 Translocation: The Results of Allogeneic Hematopoietic Stem Cells Transplantation in Children and Adults

    Tat’yana Leonidovna Gindina, N.N. Mamaev, O.V. Paina, A.S. Borovkova, P.V. Kozhokar’, O.A. Slesarchuk, Ya.V. Gudozhnikova, E.I. Darskaya, A.L. Alyanskii, S.N. Bondarenko, L.S. Zubarovskaya, B.V. Afanas’ev
    342-350
    01.07.2017
  • The IVDG Regimen is the Possible Treatment of Choice as First Line Therapy For Hodgkin’s Lymphoma in Elderly Patients with Cardiovascular and Pulmonary Comorbidity

    Kamil’ Daniyalovich Kaplanov, T.Yu. Klitochenko, A.L. Shipaeva, M.N. Shirokova, I.V. Matveeva, N.B. Lavrishina
    358-365
    01.07.2017
  • Effect of IGHV Gene Mutation Status and BCR Structure Stereotypy on Effectiveness of BR Regimen in First-Line Therapy of Chronic Lymphocytic Leukemia

    Vladimir Vladimirovich Strugov, E.A. Stadnik, A.M. Rumyantsev, T.O. Andreeva, Yu.V. Virts, Yu.V. Mirolyubova, P.A. Butylin, A.Yu. Zaritskey
    141-149
    01.04.2017
  • Relevance of Positron-Emission Therapy for Optimization of Treatment of Advanced Hodgkin’s Lymphoma Using Intensive ЕАСОРР-14 Program

    Elena Andreevna Demina, A.A. Leont’eva, G.S. Tumyan, Yu.E. Ryabukhina, E.G. Medvedovskaya, O.P. Trofimova, V.M. Sotnikov, V.B. Larionova, E.V. Paramonova, L.V. Manzyuk, N.V. Kokosadze, O.V. Mukhortova, I.P. Aslanidi, A.Yu. Zaitseva, L.A. Radkevich, M.S. Rudas, V.A. Manukova, E.A. Osmanov
    150-157
    01.04.2017
  • Acute Myeloblastic Leukemia and Myelodysplastic Syndrome: Azacitidine for Prophylactic and Preventive Purposes after Allogeneic Hematopoietic Stem Cell Transplantation

    Varvara Nikolaevna Ovechkina, S.N. Bondarenko, E.V. Morozova, I.S. Moiseev, O.A. Slesarchuk, A.G. Smirnova, O.S. Uspenskaya, Ya.V. Gudozhnikova, A.A. Osipova, V.S. Sergeev, N.N. Mamaev, L.S. Zubarovskaya, B.V. Afanas’ev
    45-51
    01.01.2017
  • Primary Mediastinal (Thymic) Large B-Cell Lymphoma

    Gayane Sergeevna Tumyan, I.Z. Zavodnova, M.Yu. Kichigina, E.G. Medvedovskaya
    13-24
    01.01.2017
  • Prevention of Acute Graft-Versus-Host Reaction after Allogeneic Unrelated Hematopoietic Stem Cell Transplantation: Comparison of Effectiveness of Treatment Regimens Based on Anti-Thymocyte Globulin and Cyclophosphamide

    Ol’ga Vladislavovna Pirogova, I.S. Moiseev, E.V. Babenko, O.A. Slesarchuk, O.V. Paina, S.N. Bondarenko, E.V. Morozova, A.L. Alyanskii, B.V. Afanas’ev
    391-397
    01.10.2016
  • Factors Affecting Course and Outcome of Chronic Lymphocytic Leukemia: Data from Hematological Hospitals of Krasnoyarsk Region

    Varvara Ivanovna Bakhtina, I.V. Demko, A.N. Narkevich, D.S. Gushchin
    413-419
    01.10.2016
  • Rearrangement of 11q23 Chromosome Region in Acute Myeloid Leukemias in Children

    Elena Vol’fovna Fleishman, O.I. Sokova, A.V. Popa, G.A. Tsaur, L.N. Konstantinova, O.M. Plekhanova, M.V. Strigaleva, E.S. Nokhrina, V.S. Nemirovchenko, O.R. Arakaev
    446-455
    01.10.2016
  • Arterial Events in Patients with Chronic Myeloid Leukemia Receiving Treatment with Second Generation Tyrosine Kinase Inhibitors

    Galina Anatol’evna Gusarova, A.G. Turkina
    474-484
    01.10.2016
  • Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemias with Hyperdiploid Karyotype

    Tat’yana Leonidovna Gindina, N.N. Mamaev, E.S. Nikolaeva, S.N. Bondarenko, O.A. Slesarchuk, A.S. Borovkova, S.V. Razumova, O.V. Pirogova, A.L. Alyanskii, L.S. Zubarovskaya, B.V. Afanas’ev
    383-390
    01.10.2016
  • Role of Positron-Emission Tomography in Prognosis of Outcomes of High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Hodgkin’s Lymphoma

    Vsevolod Gennad’evich Potapenko, N.B. Mikhailova, B.I. Smirnov, I.A. Skorokhod, D.A. Chaginskaya, V.V. Ryabchikova, I.A. Samorodova, E.I. Podol’tseva, V.V. Ipatov, I.V. Boikov, V.N. Semelev, D.A. Gornostaev, T.G. Potapenko, T.G. Kulibaba, N.V. Medvedeva, B.V. Afanas’ev
    406-412
    01.10.2016
  • Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemias: Prognostic Significance of Complex Karyotype Including del(5q), –7, del(7q) Abnormalities

    Tat’yana Leonidovna Gindina, N.N. Mamaev, S.N. Bondarenko, E.S. Nikolaeva, I.A. Petrova, O.A. Slesarchuk, A.S. Borovkova, S.V. Razumova, A.L. Alyanskii, L.S. Zubarovskaya, B.V. Afanas’ev
    271-278
    01.07.2016
  • Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis

    M.V. Barabanshchikova, E.V. Morozova, V.V. Baikov, I.M. Barkhatov, N.N. Mamaev, S.N. Bondarenko, A.L. Alyanskii, Lyudmila Stepanovna Zubarovskaya, B.V. Afanas’ev
    279-286
    01.07.2016
  • Chronic Lymphocytic Leukemia: Prognostic Significance of Minimal Residual Disease and Potential of Modern Methods of Its Diagnosis and Therapy (Literature Review)

    A.Yu. Kuvshinov, Sergei Vladimirovich Voloshi, I.S. Martynkevich, E.V. Kleina, M.A. Mikhaleva, K.M. Abdulkadyrov
    191-198
    01.04.2016
  • Results of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia with t(8;21)(q22;q22)/RUNX1-RUNX1T1 and Additional Cytogenetic Abnormalities

    Tat’yana Leonidovna Gindina, N.N. Mamaev, S.N. Bondarenko, E.S. Nikolaeva, O.A. Slesarchuk, A.S. Borovkova, O.V. Paina, S.V. Razumova, A.L. Alyanskii, L.S. Zubarovskaya
    148-154
    01.04.2016
  • Role of Patient’s Age and Comorbidities in Therapy of Chronic Lymphocytic Leukemia

    Vladimir Vladimirovich Strugov, E.A. Stadnik, Yu.V. Virts, T.O. Silina, A.Yu. Zaritskii
    162-175
    01.04.2016
  • Treatment of Relapsed and Refractory Hodgkin’s Lymphoma in Children

    N.S. Kulichkina, E.S. Belyaeva, G.L. Mentkevich, V.K. Boyarshinov, A.S. Levashov, I.V. Glekov, Aleksandr Valentinovich Popa
    13-21
    01.01.2016
  • Chronic Myeloid Leukemia: Long-Term Experience of Target Therapy

    K.M. Abdulkadyrov, Vasilii Anatol’evich Shuvaev, I.S. Martynkevich, M.S. Fominykh, N.A. Potikhonova, I.I. Zotova, V.Yu. Udal’eva, R.A. Golovchenko, N.V. Shakhvorostova, D.I. Shikhbabaeva, M.N. Zenina, S.A. Tiranova, S.A. Kudryashova, L.S. Martynenko, M.P. Ivanova, N.Yu. Tsybakova, E.V. Petrova, L.B. Polushkina, E.V. Kleina
    54-60
    01.01.2016
  • Analysis of Karyotype Aberrations in Children and Adolescents with Post-Transplantation Relapses of Acute Leukemia

    Tat’yana Leonidovna Gindina, N.N. Mamaev, E.N. Nikolaeva, I.A. Petrova, S.N. Bondarenko, A.L. Alyanskii, N.V. Stancheva, O.A. Slesarchuk, M.Yu. Aver’yanova, L.S. Zubarovskaya, B.V. Afanas’ev
    420-427
    01.10.2015
  • Hematological Improvement is a Favorable Response to Azacitidine in Patients with Acute Myeloid Leukemias and Myelodysplastic Syndromes

    Ivan Ivanovich Kostroma, S.V. Gritsaev, E.V. Karyagina, A.S. Nizamutdinova, I.S. Martynkevich, K.M. Abdulkadyrov
    413-419
    01.10.2015
  • Multiple Myeloma: 7-Year Experience of Applying Targeted Therapy in Novosibirsk and Its Results

    T.I. Pospelova, Nataliya Valer’evna Skvortsova, I.N. Nechunaeva
    267-273
    01.07.2015
  • Bone Marrow Transplantation in Patients with Acute Lymphoblastic Leukemia with Extremely Poor Prognosis: Literature Review and Case Report

    Natal’ya Nikolaevna Subbotina, A.V. Popa, I.S. Dolgopolov, V.K. Boyarshinov, R.I. Pimenov, V.V. Dailidite, G.L. Mentkevich
    331-336
    01.07.2015
121 - 160 of 186 items << < 1 2 3 4 5 > >> 

oa-antiplagiat

Антиплагиат

Make a Submission

Make a Submission

Banner ROHS

Russian Oncohematology Society

Indexing Databases

  • ISSN
  • cyberleninka cyberleninka
  • DOAJ
  • Web of Science
  • Scopus
  • Elsevier
  • CAS Source Index (CASSI)
  • NLM Catalog
  • British Library
  • РИНЦ
  • Science Index
  • SCImago
  • The European Library
  • Scholia
  • Journal Observatory
  • Scholar Google
  • IPR Smart
  • RSL
  • Ulrich's Serials Analysis System
  • ВИНИТИ
  • WorldCat
  • Research4Life
  • Lens
  • Mendeley
  • MIAR
  • OpenCitations
  • xueshu
  • OpenAlex
  • Scilit
  • Wikidata
  • na.neicon
  • Internet Archive scholar
  • ZDB catalogue
  • Keepers ISSN
  • RusMed
  • RCSI

Editor-in-Chief

Gayane Sepugovna Tumyan

ARCHIVE

2026
  • Issue 1 (2026)
2025
  • Issue 1 (2025)
  • Issue 2 (2025)
  • Issue 3 (2025)
  • Issue 4 (2025)
2024
  • Issue 1 (2024)
  • Issue 2 (2024)
  • Issue 3 (2024)
  • Issue 4 (2024)
2023
  • Issue 1 (2023)
  • Issue 2 (2023)
  • Issue 3 (2023)
  • Issue 4 (2023)
2022
  • Issue 1 (2022)
  • Issue 2 (2022)
  • Issue 3 (2022)
  • Issue 4 (2022)
2021
  • Issue 1 (2021)
  • Issue 2 (2021)
  • Issue 3 (2021)
  • Issue 4 (2021)
2020
  • Issue 1 (2020)
  • Issue 2 (2020)
  • Issue 3 (2020)
  • Issue 4 (2020)
2019
  • Issue 1 (2019)
  • Issue 2 (2019)
  • Issue 3 (2019)
  • Issue 4 (2019)
2018
  • Issue 1 (2018)
  • Issue 2 (2018)
  • Issue 3 (2018)
  • Issue 4 (2018)
2017
  • Issue 1 (2017)
  • Issue 2 (2017)
  • Issue 3 (2017)
  • Issue 4 (2017)
2016
  • Issue 1 (2016)
  • Issue 2 (2016)
  • Issue 3 (2016)
  • Issue 4 (2016)
2015
  • Issue 1 (2015)
  • Issue 2 (2015)
  • Issue 3 (2015)
  • Issue 4 (2015)
2014
  • Issue 1 (2014)
  • Issue 2 (2014)
  • Issue 3 (2014)
  • Issue 4 (2014)
2013
  • Issue 1 (2013)
  • Issue 2 (2013)
  • Issue 3 (2013)
  • Issue 4 (2013)
ALL ARCHIVE

Keywords

Most Read Articles
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2024)
    3391
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)
    1273
  • Phase 3 Clinical Trial of 300 mg Vamotinib Directly Compared with High-Dose Imatinib in Chronic Myeloid Leukemia Patients in Chronic Phase with Failure of Standard-Dose Imatinib: Interim Analysis
    889
  • Multiple myeloma (pathogenesis, clinical features, diagnosis, differential diagnosis). Part I
    847
  • Anemia of Chronic Diseases
    847

Partners

Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI
Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI

«PRACTICAL MEDICINE» LLC
115201, Moscow, 1st Kotlyakovsky Pereulok 3
Phone. +7 (495) 324-93-29
E-mail: org@bloodjournal.ru
medprint.ru


Copyright © Clinical Oncohematology. Basic Research and Clinical Practice 2026

Up